CAPITANI, Silvano
 Distribuzione geografica
Continente #
NA - Nord America 22.365
AS - Asia 11.341
EU - Europa 6.412
SA - Sud America 1.939
Continente sconosciuto - Info sul continente non disponibili 296
AF - Africa 256
OC - Oceania 35
Totale 42.644
Nazione #
US - Stati Uniti d'America 21.843
SG - Singapore 4.157
CN - Cina 2.973
BR - Brasile 1.534
VN - Vietnam 1.328
IT - Italia 1.257
UA - Ucraina 1.215
DE - Germania 1.016
HK - Hong Kong 853
TR - Turchia 790
GB - Regno Unito 720
PL - Polonia 529
FI - Finlandia 383
FR - Francia 362
SE - Svezia 303
RU - Federazione Russa 283
CA - Canada 275
IN - India 230
BD - Bangladesh 225
JP - Giappone 216
MX - Messico 157
AR - Argentina 150
ID - Indonesia 120
ZA - Sudafrica 109
IQ - Iraq 72
BE - Belgio 66
EC - Ecuador 65
NL - Olanda 65
ES - Italia 64
PK - Pakistan 64
CO - Colombia 53
MA - Marocco 40
SA - Arabia Saudita 36
UZ - Uzbekistan 36
VE - Venezuela 36
AU - Australia 31
PY - Paraguay 31
PH - Filippine 30
CL - Cile 28
LT - Lituania 26
MY - Malesia 24
EG - Egitto 22
AE - Emirati Arabi Uniti 20
IR - Iran 18
JO - Giordania 17
KE - Kenya 17
UY - Uruguay 17
HN - Honduras 16
JM - Giamaica 16
TN - Tunisia 16
AT - Austria 15
PE - Perù 15
CR - Costa Rica 14
CZ - Repubblica Ceca 14
DZ - Algeria 14
RO - Romania 14
NP - Nepal 13
IE - Irlanda 12
KR - Corea 12
KZ - Kazakistan 11
SN - Senegal 11
TH - Thailandia 11
AL - Albania 10
IL - Israele 10
CH - Svizzera 9
DO - Repubblica Dominicana 9
OM - Oman 9
AZ - Azerbaigian 8
CY - Cipro 7
GT - Guatemala 7
AO - Angola 6
BO - Bolivia 6
DK - Danimarca 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
RS - Serbia 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
GR - Grecia 5
HU - Ungheria 5
LB - Libano 5
NO - Norvegia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
EU - Europa 4
GE - Georgia 4
PA - Panama 4
QA - Qatar 4
TW - Taiwan 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
GY - Guiana 3
KW - Kuwait 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
Totale 42.308
Città #
Singapore 2.684
Ashburn 2.209
Woodbridge 2.140
Fairfield 2.015
San Jose 1.467
Houston 1.263
Jacksonville 1.261
Ann Arbor 1.074
Chandler 1.061
Beijing 888
Santa Clara 836
Hong Kong 835
Seattle 780
Wilmington 707
Cambridge 706
Warsaw 509
Izmir 428
Ho Chi Minh City 418
Los Angeles 359
Nanjing 357
New York 323
Hanoi 305
Ferrara 285
Princeton 269
Dallas 259
Council Bluffs 256
Tokyo 207
Lauterbourg 206
Boardman 201
San Diego 192
Munich 183
Shanghai 146
São Paulo 143
Buffalo 139
Milan 126
Nanchang 114
Helsinki 105
Shenyang 95
Mexico City 93
Hefei 89
London 83
Orem 78
Toronto 77
Hebei 74
Da Nang 73
Changsha 72
Tianjin 72
Jakarta 71
Dearborn 67
Bremen 65
Brussels 63
Chennai 62
Johannesburg 62
San Mateo 62
The Dalles 62
Chicago 61
Frankfurt am Main 61
Jiaxing 61
Falkenstein 58
Montreal 58
Haiphong 55
Mountain View 55
Turku 54
Atlanta 52
Jinan 52
Denver 51
Rome 51
Stockholm 51
Montréal 50
Auburn Hills 49
Kunming 48
Brooklyn 47
Falls Church 47
Addison 46
Moscow 46
Manchester 44
Mcallen 44
Rio de Janeiro 44
Belo Horizonte 41
Phoenix 39
San Francisco 37
Verona 37
Zhengzhou 37
Baghdad 35
Columbus 34
Redwood City 34
Norwalk 33
Quito 33
Boston 31
Poplar 30
Biên Hòa 29
Ankara 28
Bologna 28
Dong Ket 28
Philadelphia 28
Mumbai 26
Naples 26
Tashkent 26
Augusta 25
Curitiba 24
Totale 28.650
Nome #
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/mTOR signaling 396
Trattato di Anatomia Umana 392
Trattato di Anatomia Umana 336
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report 323
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 300
Cisplatin cytotoxicity in organ of Corti-derived immortalized cells. 292
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 290
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 285
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 280
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 280
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 279
Up-modulation of PLC-beta2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: A promising target for preventing progression of TNBC 268
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 259
Gentamicin-induced cytotoxicity involves protein kinase C activation, glutathione extrusion and malondialdehyde production in an immortalized cell line from the organ of corti 258
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 258
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 257
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 255
CD133 in Breast Cancer Cells: More than a Stem Cell Marker 254
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 252
Antiangiogenic activity of the MDM2 antagonist nutlin-3 250
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 249
Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells 248
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 242
Cisplatin-induced apoptosis in human promyelocytic leukemia cells 241
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 239
Determination of histamine in the whole blood of colon cancer patients 238
Ethanolic extract from Hemidesmus indicus (Linn) displays otoprotectant activities on organotypic cultures without interfering on gentamicin uptake 237
Accelerated functional maturation of isolated neonatal porcine cell clusters: In vitro and in vivo results in NOD mice 236
Discrete subcellular localization of phosphoinositidase C β, γ and δ in PC12 rat pheochromocytoma cells 236
In triple negative breast tumor cells, PLC-beta 2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness 233
Analysis by confocal microscopy of the behavior of heat shock protein 70 within the nucleus and of a nuclear matrix polypeptide during prolonged heat shock response in HeLa cells 231
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 227
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 226
Fhit protein expression in human gastric cancer and related precancerous lesions 226
Immunocytochemical analysis of phosphatidylinositol-specific phospholipase C in PC12 cells: predominance of the δ isoform during neural differentiation 223
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process 222
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 221
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 221
Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3. 218
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 217
Extracellular HIV-1 tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid jurkat cells 216
Cisplatin ototoxicity in the sprague dawley rat evaluated by distortion product otoacoustic emissions 215
Apoptosis in the OC-k3 immortalized cell line treated with different agents 215
VAV PROMOTES DIFFERENTIATION OF HUMAN TUMORAL MYELOID PRECURSORS 215
Increased phosphorylation of nuclear substrates for rat brain protein kinase C in regenerating rat liver nuclei 214
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 212
Nuclear protein kinases in rat liver: evidence for increased histone H1 phosphorylating activity during liver regeneration. 212
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells 212
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix 210
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 208
Lipid phosphorylation in isolated rat liver nuclei. Synthesis of polyphosphoinositides at subnuclear level 208
Spatial distribution of lamin A and B1 in the K562 cell nuclear matrix stabilized with metal ions 206
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells 206
Mass spectrometry-based identification of Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells 206
Vav1 downmodulates Akt in different breast cancer subtypes: A new promising chance to improve breast cancer outcome 205
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 204
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 204
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 203
HIV-1 Tat induces tyrosine phosphorylation of p125(FAK) and its association with phosphoinositide 3-kinase in PC12 cells 202
Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients 202
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 201
Exogenous human immunodeficiency virus type‐1 Tat protein selectively stimulates a phosphatidylinositol‐specific phospholipase C nuclear pathway in the Jurkat T cell line 200
Changes of nuclear PI-PLC γ1 during rat liver regeneration 200
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 200
Museologia Scientifica e Naturalistica 199
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells 196
From two dimensional (2D) to three dimensional (3D) analysis by confocal microscopy 195
Nuclear inositol lipids in friend erythroleukemia cells. Changes related to differentiation induced by hexamethylenebisacetamide 195
Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells 194
Retinoic acid maintains differentiated cell morphology and functions in long-term cultured porcine hepatocytes: Obtaining functional cells for prolonged treatments with bioartificial liver 194
Enhanced resolution of specific chromosome and nuclear regions by reflectance laser scanning confocal microscopy 194
The CD4 receptor plays essential but distinct roles in HIV‐1 infection and induction of apoptosis in primary bone marrow GPIIb/IIIa+ megakaryocytes and the HEL cell line 192
hnRNP K in PU.1-containing complexes recruited at theCD11bpromoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells 191
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 191
Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes 190
ANNALI DELL'UNIVERSITÀ DI FERRARA. SEZIONE: MUSEOLOGIA SCIENTIFICA E NATURALISTICA - Università degli Studi di Ferrara 188
Nuclear translocation of protein kinase C-α and -ζ isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid 188
Vav1 modulates protein expression during ATRA-lnduced maturation of APL-derived promyelocytes: A proteomic-based analysis 187
Mitogenic effects of Brazilian arthropod venom on isolated islet beta cells: In vitro morphologic ultrastructural and functional studies 186
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 186
Multiple biological responses activated by nuclear protein kinase C. 186
Changes in ribonucleoprotein particle and chromatin organization induced by liposomes in isolated nuclei 184
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication 183
Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation 183
Threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin 182
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 182
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 180
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells 180
Phosphatidylinositol 3-kinase in HL-60 nuclei is bound to the nuclear matrix and increases during granulocytic differentiation 179
Extracellular HIV-1 TAT protein induces the rapid ser133 phosphorylation and activation of CREB transcription factor in both jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells 179
Uptake and phosphorylation of phosphatidylinositol by rat liver nuclei. Role of phosphatidylinositol transfer protein 179
Museologia Scientifica e Naturalistica, Annali dell'Università di Ferrara 179
Annali dell'Università di Ferrara, sez. Museologia scientifica e naturalistica 178
Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-zeta translocation to the nucleus of NGF-treated PC12 cells. 178
AKT1 (v-akt murine thymoma viral oncogene homolog 1). Atlas Genet Cytogenet Oncol Haematol. May2009. http://AtlasGeneticsOncology.org/Genes/AKT1ID355ch14q32.html (This paper should be referenced as such) 178
H2B nucleohistone - phospholipid interactions. Thermal denaturation and ultrastructural analysis 177
Decrease in nuclear phospholipids associated with DNA replication 176
The nuclear phosphoinositide 3-kinase/AKT pathway: A new second messenger system 176
Museologia Scientifica e Naturalistica, Annali dell'Università di Ferrara. 175
Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells 175
Totale 22.026
Categoria #
all - tutte 185.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.358
Totale 190.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.598 85 224 176 198 154 134 97 165 89 236 267 773
2022/20232.449 271 130 99 311 424 362 66 240 271 25 142 108
2023/20241.051 126 164 45 30 66 150 49 102 31 19 21 248
2024/20255.042 150 125 415 185 681 444 202 317 693 563 699 568
2025/202615.170 1.553 706 1.341 2.029 2.184 892 1.644 840 1.410 1.694 555 322
2026/2027373 373 0 0 0 0 0 0 0 0 0 0 0
Totale 42.644